Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Peptivo vs Royal Medical Center

Peptivo
Graded #330

Higher grade

vs+10.700000000000003
Royal Medical Center
Graded #492

Lower grade

The verdict

Peptivo takes it — 60.1/100 to 49.4/100.

Peptivo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Peptivo is a 100% online GLP-1 weight-loss telehealth service offering compounded medication made in the USA at FDA-registered labs, with same-day provider visits and 24/7 messaging.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePeptivo +23
45
22
Dose & formulationPeptivo +11
53
42
Clinical oversightPeptivo +14
76
62
Labs & monitoringRoyal Medical Center +21
65
86
FulfillmentPeptivo +26
74
48
Contract termsEven
55
55
Peptivo · left barRoyal Medical Center · right bar

The numbers

MetricPeptivoRoyal Medical Center
WeighScore60.1/10049.4/100
GradeCC
Scorecard rank#330#492
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosed$450/mo (2.5 mg dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Peptivo

Graded #330 · C

Strengths

  • Low entry pricing — GLP-1 weight-loss plans starting at $169/mo, with free discreet shipping
  • Same-day provider visits and 24/7 provider messaging; 100% online
  • Compounded in the USA at FDA-registered labs; can also prescribe brand GLP-1 (Ozempic, Wegovy, Zepbound)
  • FSA/HSA eligible with upfront pricing

Where it loses points

  • GLP-1 products use generic names ('GLP-1 Daily Support', 'Weight Loss Boost') — semaglutide/tirzepatide not clearly broken out
  • Compounding pharmacy/lab partner not named
  • Limited published policies (privacy and terms only; no HIPAA notice or refund policy found)
  • Not LegitScript-certified (no certification displayed)
Royal Medical Center

Graded #492 · C

Strengths

  • Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
  • Tirzepatide pricing fully itemized by dose tier ($450 / $650 / $800 / $1,100) — more transparent than 'starting at' floors
  • All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
  • Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
  • Florida physician with 30+ years of practice — a strong physician-led care signal

Where it loses points

  • Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
  • Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
  • No LegitScript badge displayed
  • States served not enumerated — site says 'nationwide' with no state list
  • Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard